Michael J. Fox Foundation for Parkinson's Research
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michael J. Fox Foundation for Parkinson's Research sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
Michael J. Fox Foundation for Parkinson's Research: 14 sponsored US clinical trials, 5 recruiting.
Michael J. Fox Foundation for Parkinson's Research sponsors 14 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinson Disease, with 7 trials.
Top-decile sponsor footprint
Michael J. Fox Foundation for Parkinson's Research ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
14 total, page 1 of 1
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
NCT07020026
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
NCT07265596
Parkinson Progression Marker Initiative Online (PPMI Online)
NCT05065060
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
NCT06719583
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
NCT04507139
PPMI Tau PET Imaging
NCT04906590
FoxBioNet: ECV (Extracellular Vesicle) 004
NCT04603326
Fox BioNet Project: ECV-003
NCT03775447
Fox BioNet Project: LRRK2-002
NCT03545425
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
NCT03170063
Systemic Synuclein Sampling Study (S4)
NCT02572713
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
NCT01803945
Fox Investigation for New Discovery of Biomarkers
NCT01705327
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Michael J. Fox Foundation for Parkinson's Research pipeline
5 recruiting of 14 indexed (36% open); 7 completed (50%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Parkinson Disease (7 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michael J. Fox Foundation for Parkinson's Research: open-pipeline peers nationwide
Peers matched on 14 registered trials and 36% open enrollment, not the therapeutic-area sidebar.
Michael J. Fox Foundation for Parkinson's Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 36% open enrollment (± trial volume)
- BioNTech SE · 36% recruiting · 53 trials
- Trustees of Dartmouth College · 35% recruiting · 31 trials
- Stemline Therapeutics · 35% recruiting · 17 trials
- CooperVision International Limited (CVIL) · 36% recruiting · 11 trials
Related
What to do with this Michael J. Fox Foundation for Parkinson's Research page
14 registered trials is a research-attention snapshot, not an endorsement of Michael J. Fox Foundation for Parkinson's Research or any single study.
- 5 of Michael J. Fox Foundation for Parkinson's Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Parkinson Disease is the condition Michael J. Fox Foundation for Parkinson's Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Michael J. Fox Foundation for Parkinson's Research pipeline card: 14 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.